Hyoscon

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hyoscon

Property Description
Active Ingredient Hyoscine Butylbromide (Butylscopolamine bromide)
Primary Forms Film-coated tablets, Solution for injection
Pharmacological Class Anticholinergic Agent / Antispasmodic
General Purpose Relief from smooth muscle spasms and internal cramping
Origin Semisynthetic derivative of a natural alkaloid

Hyoscon is a specialized medicine designed to provide relief from painful, involuntary contractions of the internal smooth muscles, commonly known as cramps or spasms. Its classification as a peripherally acting antispasmodic agent means it addresses the underlying cause of the pain by promoting muscle relaxation rather than merely masking the sensation. This focus on smooth muscle is critical for managing cramping associated with the gastrointestinal, urinary, and biliary tracts; it is widely utilized for spasm management.


What Type of Medicine is Hyoscon?

Hyoscon belongs to the core pharmacological class of anticholinergic agents, specifically categorized as an antispasmodic. This type of medicine works by targeting and temporarily blocking specific receptors, known as muscarinic acetylcholine receptors, found on smooth muscle tissue. By interrupting the signaling chemical that triggers muscle cells to contract, Hyoscon achieves targeted smooth muscle relaxation. Hyoscine Butylbromide is used to reduce gastrointestinal motility and spasm. This indicates the medicine eases discomfort by relaxing the digestive tract's smooth muscles, making it suitable for managing typical scenarios involving abdominal cramping.


Composition and Origin of Hyoscine Butylbromide

The single active ingredient in Hyoscon is Hyoscine Butylbromide, also known as Butylscopolamine bromide. This substance is a semisynthetic derivative of naturally occurring belladonna alkaloids, specifically originating from scopolamine, but its chemical structure has been modified. This modification transforms it into a quaternary ammonium compound, a structure that prevents it from easily crossing the blood-brain barrier. This design ensures the medicine is peripherally acting, concentrating its activity directly on the spastic muscles of the internal organs.


Available Forms of Hyoscon

Hyoscine Butylbromide is prepared and supplied in distinct dosage forms. The primary forms of Hyoscon are film-coated tablets, intended for the oral route of administration, and a sterile solution for injection contained within an ampoule. The availability of both the oral form and the intramuscular/intravenous injectable form provides flexibility for both convenient and acute, severe spasm management. These preparations confirm that Hyoscon utilizes a single, focused active ingredient.

What side effects are possible with Hyoscon?

The officially documented adverse effects and safety profile of Hyoscine Butylbromide (Hyoscon) are defined by formal regulatory classifications based on clinical and post-marketing data.

Classification of Officially Documented Adverse Reactions

The most frequently observed adverse reactions are categorized as Common, affecting up to 1 in 10 users. These include dry mouth, tachycardia (increased heart rate), constipation, and accommodation disorders (transient visual disturbances). Effects less frequently documented include uncommon reactions such as various skin reactions and changes in sweating (dyshidrosis), and rare reactions, most notably urinary retention.

Serious Reactions and Systemic Safety

Adverse events are formally grouped into System-Organ-Classes. The label notes potentially serious adverse reactions, which are generally classified as Not Known (cannot be estimated from available data). These include severe hypersensitivity events, such as anaphylactic shock, and significant cardiovascular effects, including marked hypotension and severe tachycardia.

Population-specific safety considerations include official cautions for the injection form in patients with underlying cardiac disease. Furthermore, caution is advised for individuals prone to certain conditions, such as narrow angle glaucoma or conditions leading to urinary outlet obstructions. The official safety documents also constrain its use, noting the medicine should not be taken on a continuous daily basis or for extended periods without medical investigation of the cause of abdominal pain.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Hyoscon (Hyoscine Butylbromide) is documented in regulatory materials to result in an acute exaggeration of its anticholinergic effects, which necessitates immediate medical intervention.

Documented Overdose Manifestations

The officially described manifestations primarily involve key physiological systems:

  • Anticholinergic Signs: These commonly include pronounced tachycardia (fast heart rate), dry mouth, urinary retention, reddening of the skin, and transient visual disturbances.
  • Life-Threatening Potential: Regulatory documents note the possibility of severe outcomes, particularly following parenteral administration, which include respiratory paralysis, Cheynes-Stokes respiration, and, in rare instances, coma.

Emergency Actions and Required Care

It is mandatory to seek immediate medical attention if an overdose is suspected. Urgent help is also required if a painful, red eye develops with loss of vision, which necessitates urgent ophthalmological advice. Hospital monitoring is required for patients with underlying cardiac conditions.

Official Treatment and Monitoring: The regulatory profile confirms that overdose symptoms respond to parasympathomimetics. Officially defined supportive management measures for a suspected oral overdose include gastric lavage and the administration of activated charcoal. Catheterisation may be necessary for urinary retention.

Population-Specific Notes: Geriatric patients are noted to be particularly susceptible to severe anticholinergic side effects such as increased urinary retention and dry mouth. Children may exhibit a paradoxical reaction of hyperexcitability following large doses.

Therapeutic Uses of Hyoscon

What Hyoscon Treats: Main Uses and Benefits

Hyoscon is an antispasmodic medication primarily used to help ease symptoms related to painful cramping and spasms across several bodily systems.

Targeted Relief for Severe Colicky Pain and Acute Spasms

The medication is commonly used across conditions presenting with acute, disruptive episodes of pain, particularly the sharp, intense cramping known as colicky pain. It is applied in clinical settings that involve acute or unstable symptom patterns, and is considered relevant in conditions presenting with significant discomfort, such as those associated with severe colicky pain. This supportive relief helps ease the overall symptom burden and may assist with managing the intensity of these difficult episodes.

Quick Fact: Symptomatic support for Spasmodic Pain

Managing Symptoms of Irritable Bowel Syndrome (IBS) and Chronic Cramping

The medication is relevant in conditions characterized by periods of heightened symptoms and is commonly used for symptomatic management of Irritable Bowel Syndrome (IBS) and abdominal discomfort. This supportive care contributes to improved day-to-day comfort when symptoms interfere with routine activities. It is also applied in addressing symptoms of increased muscular activity, such as the painful contractions of the uterus that cause primary dysmenorrhea (menstrual cramps).

Eligibility and Restrictions for Use

Hyoscon (hyoscine butylbromide) is a spasmolytic medication used to relieve spasms of the gastrointestinal, biliary, and urinary tracts. Its suitability for use depends on a patient's pre-existing health conditions.

Who Can Use Hyoscon?

Most individuals experiencing painful spasms in the abdominal or pelvic area can use this medication, provided they do not have any specific contraindications. It is typically used for conditions like Irritable Bowel Syndrome (IBS), renal colic, and biliary colic.


Who Cannot Use Hyoscon?

Due to its anticholinergic properties, Hyoscon is contraindicated in patients with certain conditions as it may worsen their symptoms. The main contraindications include:

Condition Reason for Contraindication
Myasthenia Gravis May worsen muscle weakness.
Narrow-Angle Glaucoma Risk of increasing intraocular pressure.
Untreated Urinary Retention Often related to prostate enlargement (prostatic hypertrophy).
Gastrointestinal Obstruction Mechanical stenosis, paralytic ileus, or megacolon.
Tachycardia May further accelerate heart rate.
Hypersensitivity Known allergy to hyoscine butylbromide or its components.

It is crucial to inform a healthcare provider of any existing heart conditions, such as cardiac failure or coronary heart disease, as caution and close monitoring are advised, particularly with parenteral (injectable) administration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines documented interactions based strictly on official regulatory information for Hyoscon (Hyoscyamine/Hyoscine).

Documented Pharmacodynamic Interactions

Co-administration with agents that possess anticholinergic properties may lead to additive adverse effects due to combined cholinergic blockade. Interacting medicine categories include other antimuscarinics, certain antihistamines, phenothiazines, tricyclic antidepressants, and Monoamine Oxidase (MAO) Inhibitors. Specific medications mentioned in official labeling for this interaction include amantadine and haloperidol.

Documented Pharmacokinetic and Procedural Constraints

Interacting Product Category Constraint or Requirement
Antacids May interfere with absorption; must be administered separately. Official documents instruct to take this drug before meals and antacids after meals.
Oral Medications Systemic absorption may be delayed due to reduced gastrointestinal motility caused by this drug.

Interaction with Anticoagulant Drugs

For injectable formulations (e.g., Hyoscine Butylbromide), the intramuscular route of administration is restricted in patients receiving anticoagulant drugs. This is due to the potential risk of intramuscular hematoma. Subcutaneous or intravenous administration is generally permitted for these patients.

Mechanism of Action

Antagonism at Peripheral Muscarinic Receptors

Hyoscon, containing Hyoscine Butylbromide, exerts its mechanism by acting as a competitive antagonist at the muscarinic acetylcholine receptors (predominantly M3) found on smooth muscle cells. The molecule binds to these receptors, preventing the neurotransmitter acetylcholine (ACh) from activating them, thereby modulating signaling output in the parasympathetic nervous system pathway that controls involuntary muscle activity. The drug's quaternary ammonium structure prevents it from readily crossing the blood-brain barrier (BBB), ensuring the antimuscarinic activity is peripherally concentrated on the smooth muscles of the gastrointestinal, urinary, and biliary tracts.


Interruption of the Intracellular Ca^2+ Signaling Cascade

The interruption of receptor activation initiates a critical mechanistic cascade inside the smooth muscle cell. Specifically, the blockade inhibits the downstream Gq-protein signaling, which prevents the release of calcium ions ( Ca^2+) from intracellular stores. Since Ca^2+ is the essential ion for muscle fiber contraction, limiting its availability reduces the muscle's contractile state and facilitates smooth muscle relaxation.

Dosage and Administration Information

The usage of Hyoscon (Hyoscine Butylbromide) in clinical practice is based on parameters that determine the administration route, quantity, and overall treatment duration, ensuring standardized application.

Administration Routes and Forms

Hyoscon is prepared as film-coated tablets for oral intake and as a solution for injection for parenteral administration, utilizing the intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes.

Dosing Regimens and Frequency

The standard adult dosing regimen is route-dependent:

  • Oral Dose: The typical dose is 10 mg to 20 mg per unit, which may be administered three to five times daily.
  • Parenteral Dose: The standard acute dose is 20 mg. This dose is permitted to be repeated after 30 minutes if necessary, provided the total daily intake via injection does not exceed 100 mg.

Specific Administration Conditions

For oral use, the tablets are intended to be swallowed whole with water and not crushed or chewed. When the injectable form is used, particularly via the intravenous route, it is administered slowly and may require prior dilution with 0.9% sodium chloride or glucose solution. Furthermore, the injectable form is generally not recommended for use in children, and oral tablets have a specific exclusion for children under six years of age.

Duration of Use Protocol

The medicine is intended for short-term, symptomatic relief. Hyoscon is not for continuous use or for extended periods without medical investigation of the underlying abdominal symptoms. This defined protocol characterizes its purpose as an acute or temporary agent.

Recent Clinical Evidence

Research evidence / Overview of Studies for Hyoscon

Evidence for Use in Acute Abdominal Cramping and Spasm

Research examined Hyoscon primarily in the context of conditions characterized by fluctuating or episodic manifestations. These studies often focused on outcomes related to systemic or functional imbalance that can accompany these conditions. The way symptoms change over short periods of time was studied for how it relates to outcomes reflecting daily functioning or activity level. This body of evidence is particularly relevant in trials assessing short-term or episodic symptom patterns during phases of heightened symptom activity.

The studies monitored changes related to episodic or acute symptom patterns. Research highlights changes measured during the specific study period. The research indicates the results apply only to the populations studied. Evidence is limited regarding the long-term impact on these conditions, as the follow-up durations were limited in many of the initial trials.

Evidence for Symptomatic Management of Irritable Bowel Syndrome (IBS)

This block was evaluated in systematic reviews and meta-analyses, which examined the use of Hyoscon for managing the recurrent symptoms of Irritable Bowel Syndrome (IBS), focusing on outcomes like pain frequency and global symptom relief. The data show patterns related to certain changes in outcomes related to physical discomfort measured during the study period. However, for specific measures of activity and discomfort, the findings were mixed across various studies. Subgroup findings are uncertain when looking at specific patient characteristics, and sample sizes were modest in some analyses focusing on these specific patient-reported outcomes describing perceived discomfort.

Areas of Uncertainty and Research Gaps

Long-term effects are not fully established, and research is ongoing to provide more information on patterns observed over defined time intervals. Evidence quality varies across studies, and many of the early trials used relatively modest sample sizes. Certainty remains low for some detailed findings, and the evidence for certain groups remains insufficient. This research provides context but not individual predictions. The findings describe group patterns, not personal outcomes, and the study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Hyoscon (FAQ)

Q: What is Hyoscon and what is it used for?

A: Hyoscon is a medication containing the active substance hyoscine butylbromide. It is generally used to help relieve symptoms associated with cramps or spasms in the digestive tract and bladder. It is designed to act as an antispasmodic agent.


Q: How quickly does Hyoscon begin to work?

A: Following administration, the effects of Hyoscon may begin to be noticed relatively quickly. Clinical observations suggest that the onset of action may occur within a short timeframe, though the precise speed can vary among individuals and depends on the route of administration.


Q: Does Hyoscon have side effects?

A: Like all medicines, Hyoscon may be associated with side effects, though not everyone experiences them. Common side effects often involve dry mouth and mild dizziness. Individuals are encouraged to discuss any concerns regarding potential effects with a healthcare professional.


Q: Can I take Hyoscon with other medications?

A: The simultaneous use of Hyoscon with certain other medications, such as tricyclic antidepressants, antihistamines, or quinidine, may require caution. It is advisable to consult a qualified healthcare provider regarding the use of Hyoscon alongside any other treatments to understand potential interactions.


Q: Is Hyoscon suitable for all ages?

A: The suitability of Hyoscon varies depending on the specific product formulation and the individual's age. Certain formulations may not be recommended for use in children under a specific age. A healthcare provider can determine the appropriate use based on a complete medical assessment.

How should Hyoscon be stored and disposed of?

How to Store and Dispose of Hyoscon?

Storage Requirements

Official regulatory labeling dictates that Hyoscon must be stored at room temperature, typically below 25°C (77°F). It is explicitly required to not refrigerate or freeze the medicine. The product must be kept in its original container or carton to protect it from light and moisture. As a safety precaution, the medicine must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Proper disposal is essential to protect the environment. Do not dispose of unused or expired Hyoscon in household waste or via wastewater (such as flushing down a toilet or sink). Instead, the medicine should be returned to a pharmacist or collected through a local pharmaceutical take-back program, following all local requirements. For single-use liquid forms, any portion remaining in an opened container must be immediately discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hyoscon found in:

A-Z Index: